| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |